Image 1 of 1
Bedfont NObreath V2 FeNO Analyser with Accessories and 50 Mouthpieces
Measure airway inflammation with the NObreath Breath FeNO Analyser for the diagnosis and management of Asthma. Conformed to ERS and ATS guidelines, the NObreath makes measuring FeNO quick and easy with the ability to monitor airway inflammation in both adult and paediatric patients.
The benefits of measuring FeNO:
FeNO testing is a cost-effective way of improving the entire Asthma Patient Care Continuum. (1)
Identifying Type 2 Airway Inflammation and assisting in Asthma diagnosis. (2,3)
Determining ICS responsiveness and optimising ICS therapy. (2,4)
Uncovering non-adherence to ICS treatment. (5)
Reducing exacerbation rate by up to 50%. (6)
Identifying appropriate Patients for Biologics and monitoring their response. (7,8)
Resources:
Bedfont NObreath Product Brochure
References:
Menzies-Gow et al. 2020.
Dweik et al (ATS guidelines). 2011.
NICE NG80. 2017.
Hanania et al. 2018.
Heaney et al. 2019.
Syk et al. 2013.
GINA Severe Asthma guidelines. 2019.
Corren et al. 2020.
Measure airway inflammation with the NObreath Breath FeNO Analyser for the diagnosis and management of Asthma. Conformed to ERS and ATS guidelines, the NObreath makes measuring FeNO quick and easy with the ability to monitor airway inflammation in both adult and paediatric patients.
The benefits of measuring FeNO:
FeNO testing is a cost-effective way of improving the entire Asthma Patient Care Continuum. (1)
Identifying Type 2 Airway Inflammation and assisting in Asthma diagnosis. (2,3)
Determining ICS responsiveness and optimising ICS therapy. (2,4)
Uncovering non-adherence to ICS treatment. (5)
Reducing exacerbation rate by up to 50%. (6)
Identifying appropriate Patients for Biologics and monitoring their response. (7,8)
Resources:
Bedfont NObreath Product Brochure
References:
Menzies-Gow et al. 2020.
Dweik et al (ATS guidelines). 2011.
NICE NG80. 2017.
Hanania et al. 2018.
Heaney et al. 2019.
Syk et al. 2013.
GINA Severe Asthma guidelines. 2019.
Corren et al. 2020.